Virginia A. Schad, PharmD, RPh

Contributing Writer

Virginia A. Schad, PharmD, RPh, is a contributing medical author for the Haymarket Medical Network, part of the Medical Communications Group of Haymarket Media. She earned her Doctor of Pharmacy degree at the University of Pittsburgh in Pittsburgh, Pennsylvania, in 1999. For the past 20 years, Dr Schad has worked in medical communications developing numerous presentations, as well as slide libraries and kits, and editing journal articles and supplements, clinical study reports, product monographs, and program abstracts. She has also organized and implemented speaker training meetings, consultants’ meetings, advisory board meetings, roundtable meetings, and CME symposia. While Dr Schad has worked in many therapeutic areas, her areas of focus have been in endocrinology, infectious diseases, pulmonology, neurology, and cardiology.

All articles by Virginia A. Schad, PharmD, RPh

Lung Infection

Elevated Albuminuria May Be Linked to Chronic Lower Respiratory Disease Mortality

Virginia A. Schad, PharmD, RPh

June 1, 2021

Elevated albuminuria may be associated with subsequent mortality from chronic lower respiratory disease and from influenza and pneumonia.

Patient lying on Hospital bed with ventilator mask on her nose.

ATS 2021

Asthma, COPD Do Not Increase Mortality Risk in Patients With COVID-19

Virginia A. Schad, PharmD, RPh

May 17, 2021

Asthma and chronic obstructive pulmonary disease (COPD) do not appear to increase the risk of mortality in patients with COVID-19.

There appears to be accumulating evidence to support the routine use of busulfan plus melphalan as a conditioning regimen.

Critical Care

Delirium in ICU Increases Morbidity, Mortality Risk After Hospital Discharge

Virginia A. Schad, PharmD, RPh

May 3, 2021

Delirium places patients at risk for negative clinical outcomes and increased health resource utilization following an ICU stay.

Lung Infection

Bacterial Pneumonias, Bloodstream Infections in Hospitalized Patients With COVID-19

Virginia A. Schad, PharmD, RPh

April 23, 2021

Clinicians should adhere to standard best practices for preventing and empirically treating secondary infections in patients hospitalized with COVID-19.

Restrictive Lung Disease

Pirfenidone Safety, Efficacy in Progressive Fibrotic ILDs Besides IPF

Virginia A. Schad, PharmD, RPh

April 22, 2021

In patients with fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis, adding pirfenidone to treatment may attenuate disease progression.

Asthma

Adolescents With Asthma May Be More Likely to Receive Influenza Vaccination

Virginia A. Schad, PharmD, RPh

April 16, 2021

While the overall seasonal influenza vaccination rate remains low among adolescents with and without asthma, an asthma diagnosis is associated with an increased likelihood of influenza vaccination.

Asthma

Sleep-Disordered Breathing Is Common Among Children With Severe Asthma

Virginia A. Schad, PharmD, RPh

April 16, 2021

Sleep-disordered breathing is common among children with severe asthma.

COPD

Construction Workers Are at an Increased Risk for COPD

Virginia A. Schad, PharmD, RPh

April 6, 2021

Construction workers are at an increased risk for chronic obstructive pulmonary disease (COPD).

Pneumonia

Evaluation of Pneumatic Device to Regulate Tracheal Cuff Pressure to Prevent VAP

Virginia A. Schad, PharmD, RPh

March 31, 2021

Continuous regulation of cuff pressure of the tracheal tube using a pneumatic device was not superior to routine care in preventing ventilator-associated pneumonia in patients experiencing severe trauma.